Dividends to Follow: $0.04 dividends just around the corner for Bruker Corporation (NASDAQ:BRKR) shareholders.

Dividends to Follow: $0.04 dividends just around the corner for Bruker Corporation (NASDAQ:BRKR) shareholders.

Bruker Corporation (NASDAQ:BRKR) is expected to pay $0.04 on Dec 23, 2016. The indicated annual dividend is $0.16. Shareholders owning the stock before Dec 1, 2016 will be eligible to receive the payout. Based on Bruker Corporation’s current price of $23.30, the dividend is 0.17%. This dividend’s record date is Dec 5, 2016 and the announcement date is Nov 14, 2016. The stock increased 1.97% or $0.45 during the last trading session, hitting $23.3. Bruker Corporation (NASDAQ:BRKR) has declined 18.73% since April 27, 2016 and is downtrending. It has underperformed by 23.96% the S&P500.

Bruker Corporation is a designer and maker of scientific instruments, and analytical and diagnostic solutions. The company has a market cap of $3.72 billion. The Company’s operating divisions include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. It has a 26.3 P/E ratio. The Bruker BioSpin Group segment designs, makes and distributes enabling life science tools.

Insitutional Activity: The institutional sentiment decreased to 0.7 in Q2 2016. Its down 0.54, from 1.24 in 2016Q1. The ratio fall, as 24 funds sold all Bruker Corporation shares owned while 67 reduced positions. 25 funds bought stakes while 88 increased positions. They now own 105.58 million shares or 1.06% less from 106.71 million shares in 2016Q1.
Teachers Advsr has 90,094 shares for 0% of their US portfolio. Acadian Asset Limited Liability, a Massachusetts-based fund reported 6.24M shares. The Texas-based Kanaly Tru has invested 0% in Bruker Corporation (NASDAQ:BRKR). Highbridge Capital Management Limited Liability Com has invested 0.01% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Ibm Retirement Fund last reported 10,561 shares in the company. Wellington Mgmt Group Inc Llp accumulated 0% or 264,093 shares. Ladenburg Thalmann Inc reported 2,232 shares or 0% of all its holdings. Utah Retirement reported 18,989 shares or 0.01% of all its holdings. Citigroup owns 12,250 shares or 0% of their US portfolio. Thompson Rubinstein Management Or holds 1.52% or 172,300 shares in its portfolio. Piedmont Advsrs Llc has invested 0% of its portfolio in Bruker Corporation (NASDAQ:BRKR). The Michigan-based Usa Finance Portformulas has invested 0.08% in Bruker Corporation (NASDAQ:BRKR). Paloma Prtn Mgmt holds 0.01% or 57,860 shares in its portfolio. Twin Capital Mngmt has invested 0.09% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Ig Investment Management has 0% invested in the company for 38,471 shares.

Insider Transactions: Since June 6, 2016, the stock had 4 buys, and 1 insider sale for $50.83 million net activity. LAUKIEN FRANK H bought $48,631 worth of stock. 10,000 shares were bought by PACKER RICHARD A, worth $219,692 on Wednesday, August 10. On Monday, June 6 the insider LAUKIEN JOERG C sold $51.30 million.

Bruker Corporation (NASDAQ:BRKR) Ratings Coverage

Out of 11 analysts covering Bruker (NASDAQ:BRKR), 3 rate it a “Buy”, 2 “Sell”, while 6 “Hold”. This means 27% are positive. $28 is the highest target while $15 is the lowest. The $23.05 average target is -1.07% below today’s ($23.3) stock price. Bruker has been the topic of 21 analyst reports since August 20, 2015 according to StockzIntelligence Inc. The firm earned “Underperform” rating on Tuesday, April 5 by Bank of America. The rating was reinitiated by BTIG Research with “Neutral” on Friday, July 22. The rating was reinitiated by Leerink Swann on Thursday, November 10 with “Market Perform”. On Thursday, January 7 the stock rating was initiated by Deutsche Bank with “Hold”. On Monday, January 25 the stock rating was upgraded by Cantor Fitzgerald to “Buy”. Cantor Fitzgerald initiated Bruker Corporation (NASDAQ:BRKR) rating on Thursday, August 27. Cantor Fitzgerald has “Hold” rating and $22 price target. The stock has “Buy” rating given by BTIG Research on Thursday, August 20. The firm has “Buy” rating given on Thursday, November 12 by Stifel Nicolaus. Morgan Stanley initiated the shares of BRKR in a report on Tuesday, September 15 with “Equal-Weight” rating. The stock has “Buy” rating given by BTIG Research on Thursday, September 17.

More notable recent Bruker Corporation (NASDAQ:BRKR) news were published by: Prnewswire.com which released: “Bruker and Oxford Instruments Announce Acquisition of Oxford Instruments …” on November 17, 2016, also Fool.com with their article: “Why Bruker Corp. Is Crashing 12% Today” published on August 03, 2016, Prnewswire.com published: “Bruker Announces Quarterly Dividend” on November 14, 2016. More interesting news about Bruker Corporation (NASDAQ:BRKR) were released by: Prnewswire.com and their article: “Bruker Accelerates Extreme Resolution Isotope Fine Structure (IFS) Mass …” published on August 22, 2016 as well as Prnewswire.com‘s news article titled: “Bruker Reports Third Quarter 2016 Financial Results” with publication date: November 02, 2016.

BRKR Company Profile

Bruker Corporation, incorporated on February 4, 2000, is a designer and maker of scientific instruments, and analytical and diagnostic solutions. The Company’s products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples. The Company’s operating divisions include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, makes and distributes enabling life science tools based on magnetic resonance and preclinical imaging technologies. The Bruker CALID segment designs, makes and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, makes and distributes spectroscopy and microscopy instruments for the understanding of composition and structure in material science and life science samples. The BEST segment develops and makes superconducting and non-superconducting materials and devices.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment